Metabolic PET Imaging as an early biomarker of cardiac toxicity following treatment with the tyrosine kinase inhibitor sunitinib

被引:0
|
作者
Byrne, Annette T. [1 ]
机构
[1] Royal Coll Surgeons Ireland, Dept Physiol & Med Phys, Lab Tumour Biol & Mol Imaging, Dublin 2, Ireland
关键词
D O I
暂无
中图分类号
R6 [外科学];
学科分类号
1002 ; 100210 ;
摘要
O-38
引用
收藏
页码:726 / 727
页数:2
相关论文
共 50 条
  • [1] Metabolic PET imaging approaches as early biomarkers of cardiac toxicity following treatment with the tyrosine kinase inhibitor sunitinib
    O'Farrell, A. C.
    Evans, R.
    Miller, I. S.
    Conroy, E.
    Shiels, L.
    Alamanou, M.
    Hector, S.
    Silvola, J. M.
    Saraste, A.
    Liljenback, H.
    Gallagher, W.
    Cary, M.
    Knuuti, J.
    Roivainen, A.
    Byrne, A. T.
    ANGIOGENESIS, 2014, 17 (03) : 742 - 743
  • [2] Cardiac Metabolic Deregulation Induced by the Tyrosine Kinase Receptor Inhibitor Sunitinib is rescued by Endothelin Receptor Antagonism
    Sourdon, Joevin
    Lager, Franck
    Viel, Thomas
    Balvay, Daniel
    Moorhouse, Rebecca
    Bennana, Evangeline
    Renault, Gilles
    Tharaux, Pierre-Louis
    Dhaun, Neeraj
    Tavitian, Bertrand
    THERANOSTICS, 2017, 7 (11): : 2757 - 2774
  • [3] PET imaging of early response to the tyrosine kinase inhibitor ZD4190
    Min Yang
    Haokao Gao
    Yongjun Yan
    Xilin Sun
    Kai Chen
    Qimeng Quan
    Lixin Lang
    Dale Kiesewetter
    Gang Niu
    Xiaoyuan Chen
    European Journal of Nuclear Medicine and Molecular Imaging, 2011, 38 : 1237 - 1247
  • [4] PET imaging of early response to the tyrosine kinase inhibitor ZD4190
    Yang, Min
    Gao, Haokao
    Yan, Yongjun
    Sun, Xilin
    Chen, Kai
    Quan, Qimeng
    Lang, Lixin
    Kiesewetter, Dale
    Niu, Gang
    Chen, Xiaoyuan
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2011, 38 (07) : 1237 - 1247
  • [5] Proteomic analysis of off-target toxicities following treatment with the tyrosine kinase inhibitor sunitinib
    O'Farrell, Alice C.
    Lafferty, Adam
    Miller, Ian
    Evans, Rhys
    Cary, Maurice
    Murray, David
    Alamanou, Marina
    Udupi, Girish Mallya
    Shiels, Liam
    Gallagher, William M.
    Byrne, Annette T.
    CANCER RESEARCH, 2016, 76
  • [6] Use of FLT PET Imaging to Assess Tyrosine Kinase Inhibitor (TKI) Treatment Response
    Jeraj, R.
    Vanderhoek, M.
    Simoncic, U.
    Perlman, S.
    Alberti, D.
    Wilding, G.
    Liu, G.
    MEDICAL PHYSICS, 2009, 36 (06)
  • [7] Fulminant Vascular and Cardiac Toxicity Associated with Tyrosine Kinase Inhibitor Sorafenib
    Sudasena, Daryl
    Balanescu, Dinu Valentin
    Donisan, Teodora
    Hassan, Saamir
    Palaskas, Nicolas
    Kim, Peter
    Karimzad, Kaveh
    Lopez-Mattei, Juan
    Arain, Salman
    Gould, K. Lance
    Iliescu, Cezar
    CARDIOVASCULAR TOXICOLOGY, 2019, 19 (04) : 382 - 387
  • [8] Fulminant Vascular and Cardiac Toxicity Associated with Tyrosine Kinase Inhibitor Sorafenib
    Daryl Sudasena
    Dinu Valentin Balanescu
    Teodora Donisan
    Saamir Hassan
    Nicolas Palaskas
    Peter Kim
    Kaveh Karimzad
    Juan Lopez-Mattei
    Salman Arain
    K. Lance Gould
    Cezar Iliescu
    Cardiovascular Toxicology, 2019, 19 : 382 - 387
  • [9] Reproductive Toxicity Assessment of Sunitinib, A Multitargeted Receptor Tyrosine Kinase Inhibitor, in Male and Female Rats
    Coburn, Aleasha M.
    Cappon, Gregg D.
    Bowman, Christopher J.
    Stedman, Donald B.
    Patyna, Shem
    BIRTH DEFECTS RESEARCH PART B-DEVELOPMENTAL AND REPRODUCTIVE TOXICOLOGY, 2012, 95 (04) : 267 - 275
  • [10] Downregulation of miR-146a Contributes to Cardiac Dysfunction Induced by the Tyrosine Kinase Inhibitor Sunitinib
    Shen, Li
    Li, Congxin
    Zhang, Hua
    Qiu, Suhua
    Fu, Pan
    Xu, Yanfang
    FRONTIERS IN PHARMACOLOGY, 2019, 10